{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:16:05Z","timestamp":1762078565116,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NIH K23"],"award-info":[{"award-number":["NIH K23"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001345","name":"Social Science Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004427","name":"Center for Global Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL-121144"],"award-info":[{"award-number":["K23-HL-121144"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.amjcard.2018.05.024","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:22:56Z","timestamp":1528100576000},"page":"821-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-0828","authenticated-orcid":false,"given":"Tetz C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco R.","family":"Di Tullio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-0852","authenticated-orcid":false,"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Freudenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph L.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"Labovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrado","family":"Estol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Pullicino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Buchsbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.P.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-9775","authenticated-orcid":false,"given":"Siqin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.05.024_bib0001","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0002","first-page":"e240","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0003","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0005","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0006","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0007","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCHEARTFAILURE.114.001725","article-title":"Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: warfarin versus aspirin in reduced cardiac ejection fraction trial substudy","volume":"8","author":"Homma","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/14779072.6.1.57","article-title":"Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management","volume":"6","author":"Phillips","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0010","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archinte.165.11.1274","article-title":"Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure","volume":"165","author":"Rodriguez-Artalejo","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0011","first-page":"6242","article-title":"Identifying relative cut-off scores with neural networks for interpretation of the minnesota living with heart failure questionnaire","volume":"2009","author":"Behlouli","year":"2009","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0012","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1538-7836.2010.03756.x","article-title":"Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users","volume":"8","author":"Witt","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0013","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1185\/03007995.2014.957822","article-title":"International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation","volume":"30","author":"Nelson","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0014","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardfail.2008.02.011","article-title":"Predictors of medication adherence using a multidimensional adherence model in patients with heart failure","volume":"14","author":"Wu","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","article-title":"Altered intestinal function in patients with chronic heart failure","volume":"50","author":"Sandek","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0091270004271404","article-title":"Interaction of warfarin with drugs, natural substances, and foods","volume":"45","author":"Greenblatt","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0017","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.me.27.020176.001333","article-title":"Vitamin K and the oral anticoagulant drugs","volume":"27","author":"O'Reilly","year":"1976","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0019","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0149-2918(07)80081-6","article-title":"Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions","volume":"29","author":"Muszkat","year":"2007","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature02254","article-title":"Identification of the gene for vitamin K epoxide reductase","volume":"427","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0021","first-page":"20444","article-title":"VKORC1 and CD-14 genetic polymorphisms associate with susceptibility to cardiovascular and cerebrovascular diseases","volume":"8","author":"Du","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0022","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin The SAMe-TT2R2 Score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0023","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/STROKEAHA.107.508580","article-title":"Racial\/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation","volume":"39","author":"Shen","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0024","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1538-7836.2008.03075.x","article-title":"Warfarin for atrial fibrillation in community-based practise","volume":"6","author":"Rose","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0025","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0027","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijcard.2015.03.042","article-title":"Age-related medication adherence in patients with chronic heart failure: a systematic literature review","volume":"184","author":"Krueger","year":"2015","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0028","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehw213","article-title":"Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges","volume":"37","author":"Ferreira","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0029","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.05.024_bib0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Meta-analysis global group in chronic heart F. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918311962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918311962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:06Z","timestamp":1762077846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918311962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002914918311962"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.05.024","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}